GlassScriptPhysician profile
Mitchell Brian Oetken
NPI 1750721031
$17,067.52
in general payments reported to CMS, 2019-2025
14 companies · $2,375 in 2025
The $2,375 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,809 · 2020: $68.63 · 2021: $1,475 · 2022: $6,620 · 2023: $540 · 2024: $4,181 · 2025: $2,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,285 · Food and Beverage: $1,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,284.78 |
| Food and Beverage | $1,810.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $6,913.90 | 2021-2025 | Persona, Rosa, Avenir |
| Peerless Surgical INC. | $3,762.92 | 2022-2024 | |
| Crossroads Orthopedics, LLC | $2,828.17 | 2019-2021 | |
| Arthrex, INC. | $1,455.68 | 2022 | |
| Smith+Nephew, INC. | $1,379.17 | 2022-2023 | Real Intelligence |
| Stryker Corporation | $175.06 | 2019-2021 | |
| Medacta USA, INC. | $171.20 | 2025 | Gmk Sphere |
| Skeletal Dynamics INC | $132.73 | 2023 | Ijs, Implate, Align |
| Pacira Therapeutics, INC. | $105.42 | 2019-2021 | |
| Integra Lifesciences Corporation | $48.87 | 2019 | |
| Bioventus LLC | $30.39 | 2021-2022 | |
| Fx Shoulder Solutions, INC | $23.26 | 2019 | |
| Kci USA, INC. | $20.42 | 2020 | |
| Ethicon US, LLC | $20.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Oetken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.